Target intelligence / Profile preview

Immunoglobulin lambda-like polypeptide 5 (IGLL5)

Target
IGLL5
Molecular classification
Immunoglobulin superfamily domain-containing protein, Immunoglobulin lambda-like polypeptide (variable, joining, constant segments), Other (not a classical receptor, enzyme, transporter, or transcription factor)
01

Overview

Immunoglobulin lambda-like polypeptide 5 (IGLL5) is a member of the immunoglobulin superfamily, encoded by the IGLL5 gene and located within the immunoglobulin lambda locus on human chromosome 22. Unlike classical immunoglobulin genes, IGLL5 does not require somatic rearrangement for its expression; its first exon is unrelated to immunoglobulin variable genes, while the second and third exons correspond to joining and constant segments. It participates in the immune response through antigen binding, but is not a component of assembled functional antibodies in the way classical V(D)J rearranged immunoglobulins are. IGLL5 is notable for its frequent mutation in chronic lymphocytic leukemia, where its mutational spectrum reflects aberrant activation-induced cytidine deaminase (AID) activity, suggesting a role in lymphoma pathogenesis as a mutational hotspot—however, it is not a therapeutic target. IGLL5 has multiple transcript variants due to alternative splicing.

Other names
IGLL5Immunoglobulin lambda-like polypeptide 5G lambda-1Germline immunoglobulin lambda 1VL-MARIGLIGLVImmunoglobulin lambda light chain variable regionImmunoglobulin lambda-3 surrogate light chainImmunoglobulin light chain variable region EM1-PPS-4-L1-1Omega light chain protein 14.1
02

Biological functions

Antigen bindingImmunoglobulin-mediated immune response
03

Disease associations

Cancer (mutated in chronic lymphocytic leukemia and possibly other lymphoid malignancies)Other (Retina lymphoma, Isolated growth hormone deficiency; listed with limited supporting evidence)

Beyond the preview

Go deeper on Immunoglobulin lambda-like polypeptide 5 (IGLL5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda-like polypeptide 5 (IGLL5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call